AMSBIO has announced its new Trilencer-27 siRNA kit (News)

20:00 EDT 15 Aug 2012 | OBN

16 August 2012: Abingdon, UK - Gene silencing through the use of RNAi has become a primary tool for characterizing gene involvement in disease states and interactive pathways. Offering genome-wide ...

Original Article: AMSBIO has announced its new Trilencer-27 siRNA kit (News)

More From BioPortfolio on "AMSBIO has announced its new Trilencer-27 siRNA kit (News)"

Biotech & Healthcare Channels World News Life Science Events Corporate Database Market Reports Categories

Search BioPortfolio:

Clinical Trials - Daily Updated Database search the latest medical and pharmaceutical trials.

Drugs Database search our comprehensive database of prescription drugs.

Research Literature - Daily Updated Database search biomedical papers and journals.

News Quicklinks

Search Biotech, Medical and Healthcare News

Biotech News by Article Type

Biotech News by Location

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches

Searches Linking to this Story

Latest Biotechnology, Pharmaceutical and Healthcare News

Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients

Hologic Receives FDA Approval for a New Low-dose 3D Mammography (Breast Tomosynthesis) Solution for Breast Cancer Screening

United Spinal Co-Hosts 'From Within' Conference for Women Living with Physical Disabilities

Boehringer Ingelheim Presents Phase 3 Sub-Analyses for Tiotropium Across a Range of Symptomatic Asthma Patients at ATS 2013

Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine

Actavis- und Warner Chilcott-Aktien profitieren von Fusionsplänen

Mental health trust says it won't win FT status independently

BioPortfolio Limited

Publish Content

Agreements

Tools

Help

This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters at: priority@bioportfolio.com.
All rights reserved. All other trademarks recognized. Copyright © 1997-2013 BioPortfolio Limited. Site developed by Alacrify Ltd.